Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE53.9600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots55.4000/ 1
- Open / Previous Close--- / 53.9600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2737 | 54.14 |
| 09:34 ET | 1500 | 54.755 |
| 09:36 ET | 100 | 54.51 |
| 09:38 ET | 799 | 54.68 |
| 09:39 ET | 600 | 54.53 |
| 09:41 ET | 900 | 54.24 |
| 09:43 ET | 500 | 54.39 |
| 09:45 ET | 2412 | 54.705 |
| 09:48 ET | 700 | 54.48 |
| 09:50 ET | 300 | 54.47 |
| 09:52 ET | 600 | 54.63 |
| 09:54 ET | 1200 | 54.535 |
| 09:56 ET | 200 | 54.485 |
| 09:57 ET | 100 | 54.5 |
| 09:59 ET | 100 | 54.48 |
| 10:01 ET | 800 | 54.47 |
| 10:03 ET | 336 | 54.245 |
| 10:06 ET | 1357 | 54.17 |
| 10:08 ET | 500 | 53.92 |
| 10:10 ET | 557 | 53.885 |
| 10:12 ET | 384 | 54.005 |
| 10:14 ET | 200 | 53.94 |
| 10:15 ET | 1750 | 53.555 |
| 10:19 ET | 650 | 53.4495 |
| 10:21 ET | 182 | 53.29 |
| 10:24 ET | 890 | 53.465 |
| 10:28 ET | 600 | 53.455 |
| 10:30 ET | 750 | 53.3384 |
| 10:32 ET | 300 | 53.445 |
| 10:35 ET | 870 | 53.4023 |
| 10:37 ET | 100 | 53.5 |
| 10:39 ET | 100 | 53.5 |
| 10:42 ET | 700 | 53.575 |
| 10:46 ET | 300 | 53.6 |
| 10:48 ET | 700 | 53.71 |
| 10:50 ET | 300 | 53.6 |
| 10:51 ET | 500 | 53.58 |
| 10:53 ET | 1600 | 53.595 |
| 10:55 ET | 900 | 53.56 |
| 10:57 ET | 300 | 53.49 |
| 11:00 ET | 700 | 53.56 |
| 11:02 ET | 800 | 53.65 |
| 11:04 ET | 900 | 53.67 |
| 11:06 ET | 100 | 53.6875 |
| 11:08 ET | 300 | 53.76 |
| 11:09 ET | 400 | 53.835 |
| 11:11 ET | 1100 | 53.64 |
| 11:15 ET | 500 | 54.155 |
| 11:18 ET | 720 | 54.06 |
| 11:20 ET | 710 | 54.07 |
| 11:22 ET | 400 | 54.15 |
| 11:24 ET | 900 | 54.2 |
| 11:26 ET | 200 | 54.26 |
| 11:27 ET | 400 | 54.33 |
| 11:29 ET | 200 | 54.47 |
| 11:31 ET | 648 | 54.2 |
| 11:33 ET | 204 | 54.2 |
| 11:36 ET | 100 | 54.165 |
| 11:38 ET | 100 | 54.15 |
| 11:40 ET | 550 | 54.12 |
| 11:42 ET | 813 | 54.02 |
| 11:44 ET | 300 | 53.98 |
| 11:45 ET | 245 | 53.89 |
| 11:47 ET | 300 | 53.68 |
| 11:49 ET | 300 | 53.6 |
| 11:51 ET | 4850 | 53.55 |
| 11:54 ET | 100 | 53.6 |
| 11:56 ET | 300 | 53.55 |
| 11:58 ET | 100 | 53.6 |
| 12:02 ET | 700 | 53.625 |
| 12:09 ET | 100 | 53.69 |
| 12:14 ET | 200 | 53.65 |
| 12:16 ET | 402 | 53.61 |
| 12:18 ET | 100 | 53.54 |
| 12:20 ET | 470 | 53.54 |
| 12:21 ET | 300 | 53.57 |
| 12:23 ET | 100 | 53.55 |
| 12:25 ET | 100 | 53.56 |
| 12:27 ET | 954 | 53.67 |
| 12:34 ET | 200 | 53.685 |
| 12:38 ET | 600 | 53.59 |
| 12:39 ET | 700 | 53.645 |
| 12:41 ET | 100 | 53.7 |
| 12:45 ET | 652 | 53.49 |
| 12:48 ET | 100 | 53.49 |
| 12:50 ET | 100 | 53.44 |
| 12:52 ET | 100 | 53.45 |
| 12:57 ET | 125 | 53.56 |
| 12:59 ET | 300 | 53.51 |
| 01:08 ET | 100 | 53.5 |
| 01:14 ET | 300 | 53.48 |
| 01:19 ET | 426 | 53.5 |
| 01:21 ET | 300 | 53.54 |
| 01:24 ET | 100 | 53.565 |
| 01:26 ET | 300 | 53.44 |
| 01:28 ET | 406 | 53.6 |
| 01:30 ET | 400 | 53.635 |
| 01:33 ET | 308 | 53.78 |
| 01:35 ET | 100 | 53.81 |
| 01:37 ET | 1155 | 53.77 |
| 01:42 ET | 300 | 53.825 |
| 01:44 ET | 100 | 53.74 |
| 01:48 ET | 100 | 53.78 |
| 01:50 ET | 601 | 53.91 |
| 01:51 ET | 600 | 53.98 |
| 01:53 ET | 300 | 54.065 |
| 01:57 ET | 600 | 53.95 |
| 02:00 ET | 400 | 53.835 |
| 02:02 ET | 200 | 53.875 |
| 02:04 ET | 608 | 53.86 |
| 02:08 ET | 400 | 53.79 |
| 02:09 ET | 10068 | 53.69 |
| 02:11 ET | 200 | 53.8 |
| 02:13 ET | 101 | 53.82 |
| 02:18 ET | 100 | 53.795 |
| 02:20 ET | 690 | 53.77 |
| 02:22 ET | 100 | 53.82 |
| 02:24 ET | 100 | 53.83 |
| 02:27 ET | 455 | 53.89 |
| 02:29 ET | 600 | 53.895 |
| 02:31 ET | 100 | 53.88 |
| 02:36 ET | 100 | 53.91 |
| 02:38 ET | 400 | 53.95 |
| 02:40 ET | 400 | 53.86 |
| 02:42 ET | 400 | 53.83 |
| 02:44 ET | 100 | 53.88 |
| 02:47 ET | 400 | 53.79 |
| 02:49 ET | 400 | 53.78 |
| 02:51 ET | 344 | 53.735 |
| 02:56 ET | 329 | 53.82 |
| 02:58 ET | 100 | 53.81 |
| 03:02 ET | 500 | 53.76 |
| 03:05 ET | 200 | 53.64 |
| 03:07 ET | 505 | 53.58 |
| 03:09 ET | 800 | 53.53 |
| 03:12 ET | 610 | 53.63 |
| 03:18 ET | 100 | 53.58 |
| 03:20 ET | 859 | 53.51 |
| 03:21 ET | 200 | 53.47 |
| 03:25 ET | 4939 | 53.625 |
| 03:27 ET | 400 | 53.7 |
| 03:30 ET | 300 | 53.745 |
| 03:32 ET | 1749 | 53.88 |
| 03:34 ET | 400 | 53.87 |
| 03:36 ET | 1453 | 53.9 |
| 03:38 ET | 200 | 53.95 |
| 03:39 ET | 711 | 53.89 |
| 03:41 ET | 767 | 53.9425 |
| 03:43 ET | 1300 | 53.86 |
| 03:45 ET | 350 | 53.79 |
| 03:48 ET | 1768 | 53.73 |
| 03:50 ET | 700 | 53.82 |
| 03:52 ET | 300 | 53.859 |
| 03:54 ET | 1705 | 53.84 |
| 03:56 ET | 5045 | 54.01 |
| 03:57 ET | 2103 | 53.96 |
| 03:59 ET | 69965 | 53.96 |
Aug 12, 2024
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Monday Aug 12, 2024 by Dow Jones
4:05PM ET on Monday Aug 12, 2024 by Dow Jones
Aug 9, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co., from 5:08PM ET on Friday Aug 09, 2024 by Dow Jones
5:08PM ET on Friday Aug 09, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Cut to $73.00/Share From $74.00 by Oppenheimer, from 11:30AM ET on Friday Aug 09, 2024 by Dow Jones
11:30AM ET on Friday Aug 09, 2024 by Dow Jones
Aug 8, 2024
*DJ Crinetics Pharmaceuticals 2Q Loss/Shr 94c >CRNX, from 4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
4:05PM ET on Thursday Aug 08, 2024 by Dow JonesCrinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
4:05PM ET on Thursday Aug 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.3B | -14.3x | --- |
Dyne Therapeutics Inc | 4.7B | -13.1x | --- |
Biohaven Ltd | 3.9B | -4.5x | --- |
Immunovant Inc | 4.8B | -16.9x | --- |
BridgeBio Pharma Inc | 4.8B | -9.7x | --- |
Iovance Biotherapeutics Inc | 3.6B | -7.0x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.3x |
Price/Sales (TTM) | 3,118.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
